Squarepoint
ZURA icon

Squarepoint’s Zura Bio ZURA Stock Holding History

Squarepoint’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$163K Buy
39,079
+11,915
+44% +$63.6K ﹤0.01% 4123
2026
Q2 		$160K Sell
27,164
-17,775
-40% -$84.7K ﹤0.01% 4113
2026
Q1 		$267K Buy
44,939
+11,138
+33% +$67.3K ﹤0.01% 3794
2025
Q4 		$177K Buy
33,801
+8,680
+35% +$34.3K ﹤0.01% 3906
2025
Q3 		$109K Buy
+25,121
New +$45.2K ﹤0.01% 4096
2025
Q2 		– Sell
-15,238
Closed -$19.7K – 5165
2025
Q1 		$19.7K Sell
15,238
-8,134
-35% -$12.8K ﹤0.01% 4440
2024
Q4 		$58.4K Sell
23,372
-22,083
-49% -$78.7K ﹤0.01% 4815
2024
Q3 		$185K Buy
+45,455
New +$170K ﹤0.01% 3715

Other funds holding ZURA

SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Pfizer
Pfizer New York $164M AUM 53.62% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Alberta Investment Management Corp (AIMCo)
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Squarepoint's ZURA Position: Q3 2026 in Review

Squarepoint increased its Zura Bio (ZURA) stake by 44% in Q3 2026, buying an estimated $63.6K and bringing the position to 39,079 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #4123.

Squarepoint first reported a position in ZURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $267K in Q1 2026. 59 funds tracked by Wall St. Rank hold ZURA as of Q3 2026.

  • Squarepoint held 39,079 shares of Zura Bio worth $163K as of Q3 2026.
  • Squarepoint bought 11,915 Zura Bio shares in Q3 2026, an estimated $63.6K.
  • Zura Bio made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4123 holding.
  • Squarepoint first reported a position in Zura Bio in Q3 2024 and has held it in 8 quarters since.
  • Squarepoint's Zura Bio position peaked at $267K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Zura Bio as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.